Patents by Inventor Neal Clifford Goodwin

Neal Clifford Goodwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150118291
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: December 12, 2014
    Publication date: April 30, 2015
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Patent number: 8822646
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides co-therapies comprising oligonucleotides plus other therapies to treat cancer.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 2, 2014
    Assignee: ProNAi Therapeutics, Inc.
    Inventors: Neal Clifford Goodwin, James Patrick McGovren
  • Patent number: 8815599
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: August 26, 2014
    Assignee: ProNAi Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Clifford Goodwin, David Olson
  • Publication number: 20130323298
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: January 28, 2013
    Publication date: December 5, 2013
    Applicants: Novosom AG, ProNAi Therapeutics, Inc.
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Patent number: 8367628
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: February 5, 2013
    Assignees: ProNAi Therapeutics, Inc., Novosom AG
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Publication number: 20120294851
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides co-therapies comprising oligonucleotides plus other therapies to treat cancer.
    Type: Application
    Filed: March 23, 2012
    Publication date: November 22, 2012
    Applicant: ProNAi Therapeutics,Inc.
    Inventors: Neal Clifford Goodwin, J. Patrick McGovren
  • Publication number: 20090324587
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides co-therapies comprising oligonucleotides plus other therapies to treat cancer.
    Type: Application
    Filed: December 1, 2006
    Publication date: December 31, 2009
    Inventors: Neal Clifford Goodwin, J. Patrick McGovren
  • Publication number: 20090220584
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: December 1, 2006
    Publication date: September 3, 2009
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza